Home Compliance Generic Pharmaceutical Companies Settle Price-Fixing Allegations ComplianceNews Generic Pharmaceutical Companies Settle Price-Fixing Allegations October 6, 2021 8 Share FacebookLinkedinTwitter Aleksandra Gigowska | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance DOJ’s First Intervention in Cybersecurity FCA Qui Tam Case Signals Continued Cyber Enforcement Compliance Relator Alleged Violation of Statutes But Didn’t Adequately Plead False Certification Compliance Heed the Warning from DOJ to Strengthen Compliance Programs